Psoriasis prevalence in adults in the United States

…, MD Mehta, CW Schupp, GC Gondo, SJ Bell… - JAMA …, 2021 - jamanetwork.com
Importance Determining psoriasis prevalence is fundamental to understanding the burden
of the disease, the populations most affected, and health policies to address the disease. …

National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2—Advances in psoriatic disease …

JM Gelfand, AW Armstrong, S Bell, GL Anesi… - Journal of the American …, 2021 - Elsevier
Objective To update guidance regarding the management of psoriatic disease during the
COVID-19 pandemic. Study Design The task force (TF) includes 18 physician voting members …

National psoriasis foundation COVID-19 task force guidance for management of psoriatic disease during the pandemic: Version 1

JM Gelfand, AW Armstrong, S Bell, GL Anesi… - Journal of the American …, 2020 - Elsevier
Objective To provide guidance about management of psoriatic disease during the coronavirus
disease 2019 (COVID-19) pandemic. Study design A task force (TF) of 18 physician …

Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model

UA Ochsner, SJ Bell, AL O'Leary… - Journal of …, 2009 - academic.oup.com
Objectives REP3123 is a fully synthetic methionyl-tRNA synthetase inhibitor in pre-clinical
development as a novel agent to treat Clostridium difficile infection (CDI). This novel agent …

[HTML][HTML] New frontiers in psoriatic disease research, part I: genetics, environmental triggers, immunology, pathophysiology, and precision medicine

…, C Ritchlin, JU Scher, R Singh, NL Ward, S Bell… - Journal of Investigative …, 2021 - Elsevier
Psoriasis is a chronic inflammatory condition characterized by systemic immune dysregulation.
Over the past several years, advances in genetics, microbiology, immunology, and …

Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-α protein therapeutic

SJ Bell, CM Fam, EA Chlipala, SJ Carlson… - Bioconjugate …, 2008 - ACS Publications
Recombinant interferon alpha-2 (IFN-α2) has proven useful for treating a variety of human
cancers and viral diseases. IFN-α2 has a short circulating half-life in vivo, which necessitates …

Safety, tolerability, systemic exposure, and metabolism of CRS3123, a methionyl-tRNA synthetase inhibitor developed for treatment of Clostridium difficile, in a phase …

…, RA Jurao, AT An, M Le, SJ Bell… - Antimicrobial agents …, 2017 - Am Soc Microbiol
Clostridium difficile causes antibiotic-associated diarrhea and is a major public health concern.
Current therapies disrupt the protective intestinal flora, do not reliably prevent recurrent …

[HTML][HTML] New frontiers in psoriatic disease research, part II: comorbidities and targeted therapies

…, NN Mehta, B Myers, Z Shi, G Yosipovitch, S Bell… - Journal of investigative …, 2021 - Elsevier
Although psoriasis and psoriatic arthritis (PsA) have been classically considered to be
diseases of the skin and joints, respectively, emerging evidence suggests that a combination of …

Management of psoriatic arthritis in patients with comorbidities: an updated literature review informing the 2021 GRAPPA treatment recommendations

CB Campanholo, AB Maharaj, S Bell, L Costa… - The Journal of …, 2023 - jrheum.org
Objective The 2021 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
treatment recommendations provide an evidence-based guide for selecting …

[HTML][HTML] Factors influencing sleep difficulty and sleep quantity in the citizen pscientist psoriatic cohort

…, S Truman, MT Wan, JJ Wu, MP Siegel, SJ Bell… - Dermatology and …, 2019 - Springer
Introduction Sleep is essential for overall health and well-being, yet more than one-third of
adults report inadequate sleep. The prevalence is higher among people with psoriasis, with …